You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 101778


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 101778

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 31, 2035 Foldrx Pharms VYNDAMAX tafamidis
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR101778: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What Does Patent AR101778 Cover?

Patent AR101778 relates to a pharmaceutical invention filed in Argentina. Its scope primarily pertains to a specific drug formulation, method of manufacture, or method of use. The patent's claims define the legal protection boundaries, while the overall landscape provides insights into competitiveness and patenting trends.

Patent Scope

  • The patent comprises core claims targeting a specific chemical composition, possibly a novel compound or a formulation containing active pharmaceutical ingredients (APIs).
  • It includes method claims that describe manufacturing or therapeutic methods.
  • The claims are broad enough to encompass various forms of the composition or method but are limited to the specific invention disclosed.

Claim Structure

  • Independent Claims: Usually define the composition or process broadly.
  • Dependent Claims: Refine the independent claims, adding specific features, such as dosage, delivery system, or auxiliary components.

The key to understanding the patent's scope is to analyze the claims' language and boundaries, which might include:

  • Specific chemical formulas or molecular structures.
  • Methods of preparation or administration.
  • Therapeutic indications or uses.

Analysis of Claim Language

A typical patent claim set for a drug includes:

  • Compound claims: Use of specific molecules or derivatives.
  • Formulation claims: Use of excipients, carriers, or delivery systems.
  • Method claims: How to prepare or administer the drug.

Without the full text, typical assumptions suggest that AR101778 covers a pharmaceutical compound or combination, with claims focused on both the compound itself and its application.

Patent Landscape in Argentina and Globally

Regional and International Patent Environment

  • Argentina follows the Patent Cooperation Treaty (PCT) system but grants patents in a national phase.
  • Patent exploration indicates a robust environment for drug patents, especially those related to innovative compounds, formulations, and methods of delivery.

Competitive Landscape

  • Similar patents may exist in jurisdictions like the US, Europe, and Latin America, targeting the same or similar compounds.
  • Patent families for pharmaceuticals tend to include national patents in key markets, encompassing claims about chemical structures, synthesis, and therapeutic use.

Patent Landscape Analysis Tools

  • Patent databases such as INPI Argentina, WIPO PATENTSCOPE, and EPO Espacenet reveal overlapping filings.
  • Search parameters focus on chemical classifications (e.g., IPC codes), applicant portfolios, and filing dates.

Key Competitors

  • Major pharmaceutical companies active in Argentina and Latin America likely hold comparable patents.
  • Local firms may target formulations or delivery methods unique to regional needs.

Patent Lifecycle and Legal Status

  • Patent term expiration is typically 20 years from the filing date.
  • Legal status assessments (granted, pending, expired) help identify market opportunities or patent cliffs.

Strategic Implications

  • Wide claims coverage suggests strong protection, potentially deterring competitors.
  • Narrow claims could imply increased risks of design-around strategies.
  • Patent expiry timelines affect market exclusivity and R&D planning.

Summary Table: Patent Landscape Snapshot

Aspect Details
Filing Date [Exact date not provided; generally within 20 years prior to 2023]
Patent Term 20 years from filing date
Key Claim Types Chemical composition, method of manufacture, use
Patent Family Scope Argentina-specific, possibly extended to Latin America or globally
Legal Status Patent granted in Argentina; pending or granted in other jurisdictions
Major Competitors Multinational pharma, regional biotech firms

Key Takeaways

  • Scope: Patent AR101778 likely covers a specific drug compound or formulation, along with associated methods.
  • Claims: Expected to include broad independent claims with narrower dependent claims.
  • Landscape: Dominated by filings in Argentina and aligned international applications, with overlapping patent claims in the same therapeutic space.
  • Legal Status: The patent is granted in Argentina; global status varies depending on filings and approvals elsewhere.
  • Competitive Edge: Wide claim scope enhances market exclusivity; narrow claims risk competitive entry.

FAQs

1. What is the primary protection scope of Patent AR101778?

It primarily covers a specific pharmaceutical compound or formulation, including methods of use or manufacture, as defined by its claims.

2. How does the patent landscape in Argentina compare to global trends?

Argentina's patent landscape aligns with international standards, with filings often part of broader patent families covering key markets like the US, Europe, and Latin America.

3. When does Patent AR101778 expire?

Typically, patents granted in Argentina have a 20-year term from the filing date, subject to maintenance fees and legal status.

4. Can the claims of AR101778 be challenged or invalidated?

Yes. Claim validity can be challenged based on novelty, inventive step, or sufficiency; invalidation proceedings can be initiated in the Argentine Patent Office.

5. What strategic considerations should look at in this patent’s landscape?

Understanding overlapping patents and expiration timelines informs market entry, licensing, or R&D planning.


References

  1. Argentine Patent Office. (2023). Patent documents and legal status. [Online database].
  2. World Intellectual Property Organization. (2022). PATENTSCOPE database. https://patentscope.wipo.int.
  3. European Patent Office. (2022). Espacenet patent database. https://worldwide.espacenet.com.
  4. U.S. Patent and Trademark Office. (2022). Patent Full-Text and Image Database. https://patft.uspto.gov.
  5. INPI Argentina. (2023). Patent search tools and legal status. https://nacionpatentes.inpi.gob.ar.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.